FDAnews Drug Daily Bulletin

CORGENTECH AND ALGORX COMPLETE MERGER CREATING LATE-STAGE COMPANY ADDRESSING PAIN MANAGEMENT

Dec. 19, 2005
A A

Corgentech Inc. and AlgoRx Pharmaceuticals, Inc. announced today that following stockholder approval of the merger by the stockholders of both companies, the merger was completed on December 15, 2005. The merger creates a late-stage company with four clinical development candidates focused on pain management and inflammation. In connection with the merger, Corgentech stockholders also approved a one-for-four reverse stock split, which was also effected on December 15, 2005.

PR Newswire (http://www.prnewswire.com/cgi-bin/stories.pl?ACCT=104&STORY=/www/story/12-16-2005/0004235300&EDATE=)